AAAAAA
Results:
1-15
|
Results: 15
Authors:
Heinzer, H
Huland, E
Huland, H
Citation: H. Heinzer et al., Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer, WORLD J URO, 19(2), 2001, pp. 111-119
Authors:
Reek, C
Conrad, S
Heinzer, H
Huland, H
Citation: C. Reek et al., Long-term follow-up after side-fire laser coagulation of the prostate withthe neodymium : YAG laser, UROLOGE A, 40(2), 2001, pp. 127-132
Authors:
Heinzer, H
Citation: H. Heinzer, To read my heart: The journal of Rachel van Dyke, J EARLY REP, 21(2), 2001, pp. 358-360
Authors:
Huland, E
Heinzer, H
Huland, H
Citation: E. Huland et al., Overview of interleukin-2 inhalation therapy, CA J SCI AM, 6, 2000, pp. S104-S112
Authors:
Atzpodien, J
Huland, E
Heinzer, H
Citation: J. Atzpodien et al., Foundation of the German Society for Immunotherapy: Significant advances in cancer treatment, ONKOLOGIE, 23(5), 2000, pp. 476-477
Authors:
Heinzer, H
Huland, E
Huland, H
Citation: H. Heinzer et al., Treatment of metastatic renal cell carcinoma. Immunotherapy versus surgical removal, UROLOGE A, 39(4), 2000, pp. 356-361
Authors:
Huland, H
Heinzer, H
Steinbach, F
Citation: H. Huland et al., Commentary - Pros and cons regarding metastatic surgery - Is there still aplace for metastatic surgery in the treatment of metastasized renal cell carcinoma?, UROLOGE A, 39(4), 2000, pp. 367-367
Authors:
Huland, E
Heinzer, H
Huland, H
Citation: E. Huland et al., A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinoma, FOL BIOL, 46(6), 2000, pp. 241-250
Authors:
Huland, E
Heinzer, H
Citation: E. Huland et H. Heinzer, Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, alpha-interferon (leucocyte) and tamoxifen, BR J CANC, 82(1), 2000, pp. 246-246
Authors:
Heinzer, H
Mir, TS
Huland, E
Huland, H
Citation: H. Heinzer et al., Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy, J CL ONCOL, 17(11), 1999, pp. 3612-3620
Authors:
Heinzer, H
Huland, H
Kuczyk, M
Citation: H. Heinzer et al., Editorial: Renal cell carcinoma - any new developments?, UROLOGE, 38(5), 1999, pp. 423-424
Authors:
Heinzer, H
Huland, E
Aalamian, M
Huland, H
Citation: H. Heinzer et al., Treatment of pulmonary metastases from kidney cell carcinoma with inhalational interleukin-2. 10-year experience Hamburger Unicenter, UROLOGE, 38(5), 1999, pp. 466-473
Authors:
Heinzer, H
Hammerer, PG
Huland, H
Citation: H. Heinzer et al., Anatomy and physiology of the male urethral sphincter and its preservationin prostatic surgery, UROL RES, 27(6), 1999, pp. 404-408
Authors:
Huland, E
Heinzer, H
Huland, H
Citation: E. Huland et al., Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2), ANTICANC R, 19(4A), 1999, pp. 2679-2683
Authors:
Huland, E
Heinzer, H
Huland, H
Citation: E. Huland et al., Immunotherapy of pulmonary metastatic renal cell carcinoma: Success dependant on risk factors?, HEP-GASTRO, 46, 1999, pp. 1257-1262
Risultati:
1-15
|